Rishi Singhal1,2, Tom Wiggins1, Jonathan Super1, Aayed Alqahtani3, Evan P Nadler4, Christian Ludwig5, Abd Tahrani5,6,7, Kamal Mahawar8. 1. Upper GI Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. 2. Department of Bariatric Surgery, Medical Director, Healthier Weight, Birmingham, UK. 3. Department of Bariatric Surgery, New You Medical Center, Riyadh, Saudi Arabia. 4. Department of Bariatric Surgery, Children's National Hospital, Washington, DC, USA. 5. Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. 6. Department of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. 7. Department of Diabetes and Endocrinology, Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK. 8. Bariatric Unit, South Tyneside and Sunderland NHS Trust, Sunderland, UK.
Abstract
BACKGROUND: Metabolic and bariatric surgery (MBS) is an effective treatment for adolescents with severe obesity. OBJECTIVES: This study examined the safety of MBS in adolescents during the coronavirus disease 2019 (COVID-19) pandemic. METHODS: This was a global, multicentre and observational cohort study of MBS performed between May 01, 2020, and October 10,2020, in 68 centres from 24 countries. Data collection included in-hospital and 30-day COVID-19 and surgery-specific morbidity/mortality. RESULTS: One hundred and seventy adolescent patients (mean age: 17.75 ± 1.30 years), mostly females (n = 122, 71.8%), underwent MBS during the study period. The mean pre-operative weight and body mass index were 122.16 ± 15.92 kg and 43.7 ± 7.11 kg/m2 , respectively. Although majority of patients had pre-operative testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (n = 146; 85.9%), only 42.4% (n = 72) of the patients were asked to self-isolate pre-operatively. Two patients developed symptomatic SARS-CoV-2 infection post-operatively (1.2%). The overall complication rate was 5.3% (n = 9). There was no mortality in this cohort. CONCLUSIONS: MBS in adolescents with obesity is safe during the COVID-19 pandemic when performed within the context of local precautionary procedures (such as pre-operative testing). The 30-day morbidity rates were similar to those reported pre-pandemic. These data will help facilitate the safe re-introduction of MBS services for this group of patients.
BACKGROUND: Metabolic and bariatric surgery (MBS) is an effective treatment for adolescents with severe obesity. OBJECTIVES: This study examined the safety of MBS in adolescents during the coronavirus disease 2019 (COVID-19) pandemic. METHODS: This was a global, multicentre and observational cohort study of MBS performed between May 01, 2020, and October 10,2020, in 68 centres from 24 countries. Data collection included in-hospital and 30-day COVID-19 and surgery-specific morbidity/mortality. RESULTS: One hundred and seventy adolescent patients (mean age: 17.75 ± 1.30 years), mostly females (n = 122, 71.8%), underwent MBS during the study period. The mean pre-operative weight and body mass index were 122.16 ± 15.92 kg and 43.7 ± 7.11 kg/m2 , respectively. Although majority of patients had pre-operative testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (n = 146; 85.9%), only 42.4% (n = 72) of the patients were asked to self-isolate pre-operatively. Two patients developed symptomatic SARS-CoV-2 infection post-operatively (1.2%). The overall complication rate was 5.3% (n = 9). There was no mortality in this cohort. CONCLUSIONS: MBS in adolescents with obesity is safe during the COVID-19 pandemic when performed within the context of local precautionary procedures (such as pre-operative testing). The 30-day morbidity rates were similar to those reported pre-pandemic. These data will help facilitate the safe re-introduction of MBS services for this group of patients.
Authors: Rishi Singhal; Islam Omar; Brijesh Madhok; Christian Ludwig; Abd A Tahrani; Kamal Mahawar Journal: Obes Res Clin Pract Date: 2022-06-08 Impact factor: 5.214
Authors: Rishi Singhal; Islam Omar; Brijesh Madhok; Yashasvi Rajeev; Yitka Graham; Abd A Tahrani; Christian Ludwig; Tom Wiggins; Kamal Mahawar Journal: Obes Surg Date: 2022-05-05 Impact factor: 3.479